Login

In the latest Shot Callers episode, Mark Mastalir, Co-CEO of Halo Neuroscience, discusses insights on the company; subscribe to the FOS Daily newsletter for updates. 00:10:00

Share On Facebook Share On Twitter

David Parker · CEO at Halo Security

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
How to Navigate Financial Disagreements as a Couple: Expert Tips from Buckingham Strategic Wealth
00:10:00
Lloyd's Reports Strong Q2 Results and Confidently Reaffirms Guidance
00:10:00
Transforming Abercrombie: A CEO's Journey to Reinvent Iconic Brands | Fran Horowitz, CEO Abercrombie
00:10:00
From Kentucky Coal to Texas Shale: The Journey of Rhett Bennett, CEO of Black Mountain Energy | Rhett Bennett, CEO, Black Mountain Energy Ltd.
00:10:00
Impact of JobKeeper and JobSeeker on Customers, Government's Role in Energy Sector, and Investment Uncertainty | Frank Calabria, CEO, Origin Energy Ltd .
00:10:00
Exploration Acceleration and High-Grade Potential in Northwest Gold Camp
00:10:00
Building a Resilient Balance Sheet for a Stronger Future | Prashant Kumar, CEO , Yes Bank Ltd.
00:10:00
Get River Diamonds Limited: Developing the Blina Alluvial Diamond Project in Western Australia
00:10:00
Mission-Driven Investing at The Venture Collective|Nicholas Shekerdemian,Founding Partner,The Venture Collective (TVC)
00:10:00
Altamira Gold's Michael Explores Brazilian Gold and Copper Prospects and Strategic Growth at One-to-One Conference
00:10:00
Randy Kurtz’s Data Driven Advisor Program: Transforming Financial Planning | Randy Kurtz, President , Upper Left Wealth Management.
00:10:00
Focused on developing and commercializing proprietary molecular diagnostic tests for early detection of cancer|James Howard,CEO,genenews ltd

© 2017 - Neuhu+